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Innovative Initiatives in Education of Professionals
The members of the Editorial BOARD of The EPMA J.
working weekly with the manuscripts and the peer-review
procedure of the journal know very well, how difficult this
task is. Different professional groups in personalised
medicine have realised that they speak “different profes-
sional languages” less understandable for others. Conse-
quently, great discoveries made / innovations triggered by
one professional group, are frequently underestimated or
even not valued at all by the others resulting in delays to the
implementation of novel developments in personalised
medicine across diverse areas. Therefore, in healthcare we
need to develop a new culture among experts in order to
promote the multidisciplinary field of personalised medi-
cine. Our message is - the innovative PPPM-related
educational programmes for professionals should be priori-
tised in the Common Strategic Framework (FP-8) as well as
in other global and corresponding national programmes.
In order to promote innovative educational programmes, in
collaboration with Springer, EPMA has developed world-
wide pioneer initiatives creating the didactic materials for
the field as follows:
A. The EPMA Journal that regularly updates both needs
and achievements in the field of PPPM in application to
major and rare pathologies.
B. The book-series “Advances in Predictive, Preventive
& Personalised Medicine” (Book-series Editor: Olga
Golubnitschaja); the book-series release is starting in
2012 with the following volumes:
& “Healthcare Overview: innovative national and in-
ternational programmes dedicated to predictive,
preventive & personalised medicine”, Volume Editor:
Vincenzo Costigliola, Brussels, Belgium (Fig.1);
& “PPPM in Diabetes mellitus”, Volume Editor:
Mahmood Mozaffari, Augusta, USA;
& “PPPM in Neurodegenerative diseases”, Volume
Editor: Silvia Mandel, Haifa, Israel;
& “Drug delivery systems: Advanced technologies
potentially applicable in personalised medicine”,
Volume Editor: Jorge Coelho, Coimbra, Portugal.
This important initiative should be obligatory supported
and well used at the European level and worldwide.
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Educational Measures for Population: Promoting
Participative Medicine
Advanced personalisation in medicine is achievable solely
in the case of participative medicine that meets the demands
of patient advocacy groups focussed on individually created
medical approaches. The reader will find a number of
positive examples in each issue of The EPMA J. and single
volumes of the book-series “Advances in PPPM” concor-
dant with this statement. It is evident that strong restrictions
in the amount of education lead to dramatic deficits and
costs that have repercussions in several branches of the
society resulting in increased pressure within healthcare
systems [1]. Our message is - new guidelines are
essential to regulate the field in favour of educational
measures for preventive programmes and advanced
healthcare systems.
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Our business is publishing. Throughout the world, we provide
scientific and professional communities with superior specialist
information – produced by authors and colleagues across
cultures in a nurtured collegial atmosphere of which we are
justifiably proud.
We foster communication among our customers – researchers,
students and professionals – enabling them to work more
efficiently, thereby advancing knowledge and learning. Our
dynamic growth allows us to invest continually all over the
world.
We think ahead, move fast and promote change: creative
business models, inventive products, and mutually benefi-
cial international partnerships have established us as a
trusted supplier and pioneer in the information age.
Predictive, preventive and personalised medicine (PPPM)
offers great promise for the future practice of medicine.
Fig. 1 Book-series “Advances in Predictive, Preventive and Personalised Medicine” in preparation by EPMA / Springer to be released in the years
2012–2015 as the didactic material for specialised educational programmes
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Essential components of this approach include well-
organised population screening protocols utilising novel
diagnostic biomarkers of disease states; targeted prevention
of common human pathologies; optimal treatment planning
and personalised medicine, resulting in substantial im-
provement of the quality of life. This approach also offers
the advantage of delivering care at potentially reduced costs
to the population at large, addressing social and ethical
issues related to healthcare access and affordability.
Springer proudly publishes The EPMA Journal on behalf
of the EPMA. The journal addresses these highly relevant
issues in editorial overviews, review articles and annotated
papers. Despite the rapid expansion in the areas of
predictive, preventive and personalised medicine, there
is, to date, no review journal dedicated to this field of
science that provides concise summaries on important
topics. Springer believes that The EPMA Journal is a
valuable addition to the scientific literature and are
confident that it will make a global contribution. This is
currently reflected in the rapidly increasing online usage
of the journal.
Springer now also publishes the forthcoming Book Series
“Advances in Predictive, Preventive and Personalised
Medicine” which serves as an extension of the journal.
This Series will serve as a basis for the education of
medical students, healthcare-providers and related disci-
plines at the various universities and medical centers.
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Oxidation of low-density lipoproteins (LDL) promotes
atherosclerosis by enhancing vascular inflammation and
foam cell formation. The corollary is that diets that
stimulate endogenous anti-oxidants may protect against
atherosclerosis. Our group has recently studied the influ-
ence of sulforaphane, an isothiocyanate derived from green
vegetables, on vascular physiology. We observed that
sulforaphane can suppress inflammatory activation of
vascular cells by inducing an antioxidant transcription
factor called Nrf2. A deeper understanding of vascular
responses to sulforaphane may inform nutritional
approaches to prevent vascular inflammation and athero-
sclerosis.
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Personalized medicine represents a new approach to the
disease prevention, primary diagnosis and individualized
therapy approaches. Traditional medical model existing for
centuries has been limited to the individual anamnesis data,
clinical signs, results from laboratory analyses and from
imaging methods and social circumstances, environment
and behavior. Diagnosis and therapy has been applied
empirically based on multicenter epidemiological studies of
large cohorts supported by an extensive development of
laboratory and imaging techniques. Nevertheless, these
approaches have not taken into account the genetic
variability (single molecular profiles) of individuals within
a population.
Personalized medicine seeks to provide an objective basis
for consideration of such individual differences using the
advances in a number of molecular profiling technologies,
including proteomic profiling, metabolic analysis, and genetic
testing (http://en.wikipedia.org/wiki/Molecular_biology). In-
formation about a patient’s protein, genetic and metabolic
profile could be used to tailor medical care to that
individual’s needs. The main challenge of personalized
medicine is to predict a disease, monitor its progression
and create stratified individualized therapies. The ultimate
goal of personalized medicine is disease detection in
asymptomatic stage and prevention of clinical manifestation
of the disease.
Educational process should meet the needs and cover all the
levels across the society. Personalized medicine will be very
demanding on personal understanding, healthcare organi-
zation and economy. Educational process should focus on
both non-professional (general) population and professio-
nals in personalized medicine. This process should start
with the field-related education already at elementary
schools as it has been already implemented in some
countries. General population should be provided with
sufficient information. Professional educational process
should involve not only universities, but also diagnostic
and pharmaceutical companies, healthcare providers /
insurance companies, communication media and related
non-profit organizations. Educational process should be
network at the national and international levels.
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It should result in national and European guidelines for
personalized medicine. This contribution highlights the
existing and proposed programs for specialized education
in personalized medicine in the Czech Republic.
Support: This study was supported by grant project
CZ.1.07/2.3.00/20.0040.
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In personalised medicine, monitoring of genome and bio-
markers, including their correlation with clinical data, is
essential. Considering the fast growing knowledge about
biomarkers and their function as well as a rapid development
of analytical techniques, specialised professional education of
clinicians and researchers in the field is essential.
In the Czech Republic we accumulate this experience by
organising educational courses for experts involved in
biomedical research, focused on biomarkers, their analytical
determination and application in different areas and concepts
of medicine. The educational courses are created as follows:
– General overview of immunoanalytical techniques
– Application of novel biomarkers in oncology
– Application of novel biomarkers in gynaecology
– The role of biomarkers in personalised medicine.
The aim is to attract attention of clinicians to the multifunc-
tional role of biomarkers and the importance of their accurate
determination, and to network the expertise of laboratories
with clinical practice. The lecturers are invited from different
areas related to the topic and intended to provide the
participants with the full overview in the issue. Professional
discussions among experts are encouraged.
Each of courses is attended by more than 20 persons from
laboratories, universities and hospitals of different regions in
the Czech Republic. The participants receive also a practical
overview by visiting the Laboratory of immunoanalysis at the
University Hospital in Plzen - one of the biggest immunoa-
nalytical laboratory in the Czech Republic.
CAN PAIN MANAGEMENT PROTOCOLS BE
EVIDENCE BASED, PHYSIOLOGICAL, SAFE AND
PERSONALIZED? NEW CHALLENGES FOR
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This contribution deals with clarification and standardization
of techniques for injection and stimulation pain relief, such as
dry needling, acupuncture, physical therapy under ultrasound
guidance. According to own experience, ultrasound (US) is
the most acceptable technique for image guidance and
monitoring pain treatment. Ultrasonography and electromy-
ography (EMG) under US guidance provides accurate
diagnostic information and could become a predictive “gold
standard” of neuromuscular disorders with performance of
effective intelligent decision guided treatment. The integrated
use of three-dimensional modeling based on the data collected
from different sources of visual information improves the
quality of diagnostics and pain syndrome treatments and
allows for performing the model-guided interventions.
Field-related educational programs are essential to integrate
the multi-fuctional expertise for the pain study and
management techniques, advanced diagnostic methods,
EMG, imaging technologies, adequate medical record
considering genetic, anatomical, histological, physiological
and other individual parameters of individual patient
profiling. We propose a designing of the complex
phantom-virtual training systems as the major component
of specialized educational programs in pain medicine. It
should be a link between theoretical training and accept-
ability of specialist to work with the patient and also an
effective tool for pre-treatment planning in specific clinical
situations and for new interventional approaches to provide
a high level of patient safety.
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